TechValidate Research on QIAGEN Digital Insights

These pages present data that TechValidate has sourced via direct research with verified customers and users of QIAGEN Digital Insights. TechValidate stands behind the authenticity of all published data. Learn more »

6,540 Customers Surveyed

44,263 Data Points Collected

355 Published TechFacts

38 Published Charts

23 Published Case Studies

Featured Research Collections for QIAGEN Digital Insights

Curated collections and slideshows of TechValidate research data on QIAGEN Digital Insights.

Selected Research Highlights

QIAGEN Customer Research

How much would you be willing to pay for a collection device with stabilizing solution compared to just a bulk stabilizing solution?

10% more for collection device vs. bulk
20% more for collection device vs. bulk
50% more for collection device vs. bulk
I would not use a bulk stabilization solution

QIAGEN Bioinformatics Customer Review

“User-friendly and intuitive…”

4.5/5 Stars

Please share details on your experience with it.

CLC Main Workbench feels much more user-friendly and intuitive to use than some of the other options I have available like for example, SnapGene.

Case Study: ARUP Laboratories and Ingenuity Variant Analysis


This case study of ARUP Laboratories is based on a March 2013 survey of Ingenuity Systems customers by TechValidate, a 3rd-party research service.

“[Ingenuity Variant Analysis] provides easy access to excellent gene variant interpretation, especially for those without a bioinformatics background. It has also greatly reduced the time from variant call to seeing “final” results.”


  • Solved the following challenges by deploying Ingenuity Variant Analysis:
    • Realized faster and easier identification of causal variants
    • Improved access to biological content including primary sources
    • Reduced the need for developing own informatics pipeline
    • Eliminated the need for creating and maintaining own up-to-date database of biomedical literature
  • Purchased Ingenuity Variant Analysis for the following reasons:
    • Access rich biological content in Ingenuity Knowledge Base plus additional sources of variant level content
    • Increase trust in the insights received from experiment
    • Access user friendly interface and no bioinformatics experience needed
    • Collaborate and share easily with colleagues and peers

Use Case

  • Uses the following applications with Ingenuity Variant Analysis:
    • DNA sequencing – Whole Genome
    • DNA sequencing – Whole Exome
    • DNA sequencing – Targeted / Gene Panel
  • Sequencing data is from the following platforms:
    • Illumina MiSeq
    • Illumina Genome Analyzer (GA) / HiSeq
    • Ion Torrent PGM
    • Complete Genomics


  • Chose Ingenuity Systems over the following solutions:
    • Cartagenia
    • Knome
    • VAAST / Omicia
    • In-house developed software
  • Saves 1 to 3 days per sample using Ingenuity Variant Analysis for DNA variant annotation and analysis.
  • Reduced time to results by 10 to 49% by using Ingenuity Variant Analysis for DNA variant annotation and analysis.
  • Rated the following Ingenuity Variant Analysis capabilities in terms of how differentiated they are compared to other data analysis solutions:
    • Speed: 5 (strongly differentiated)
    • Accurate evidence: 4 (very differentiated)
    • Accessibility/ ease of use: 4 (very differentiated)
    • Sharing with colleagues/peers: 5 (strongly differentiated)
  • Is very satisfied with the ease of use of Ingenuity Variant Analysis.

QIAGEN Bioinformatics Customer Statistic

89% of surveyed organizations perform somatic clinical NGS variant calling (Secondary analysis) within their country.


Case Study: Educational Institution


This case study of a educational institution is based on a July 2013 survey of Ingenuity IPA customers by TechValidate, a 3rd-party research service. The profiled organization asked to have their name blinded to protect their confidentiality.

“IPA is very useful and has become a daily tool of my research.”


  • Solved the following challenges since deploying IPA for RNA sequencing analysis:
    • Improved understanding of the structure of different isoforms
    • Can now distinguish different isoforms
    • Can more clearly identify biologically relevant isoforms
  • Purchased IPA for RNA sequencing analysis for the following reasons:
    • Interpret the impact of expression changes in the context of biological processes, disease and cellular phenotypes, and molecular interactions
    • Compile targeted bibliographies with experimental evidence linking their differentially expressed isoforms to biological processes, disease, and molecular interactions

Use Case

  • Uses the following species in their RNA seq analysis:
    • Humans
    • Mice
  • Uses the following upstream analysis packages to generate RNA-Seq expression values:
    • EdgeR


  • Purchased IPA for RNA seq analysis over the following competitors:
    • GeneGo
  • Rates the following IPA capabilities compared to the competition:
    • Faster time to insights: extremely differentiated
    • Ease of use: extremely differentiated
    • Novel insights: extremely differentiated
    • Deeper analysis: extremely differentiated
  • Is extremely satisfied with the value for identifying biologically relevant isoforms from RNA seq data using IPA.

Variant Analysis users solving analysis bottlenecks and getting actionable data results.

How confident are you in the insights and results obtained from Variant Analysis for your experiments?

Extremely confident: 0%
Very confident: 43%
Confident: 57%
Not confident: 0%

More to Explore

About QIAGEN Digital Insights

QIAGEN offers industry-leading applications for the analysis, interpretation, and reporting of biological data. Understanding raw data is one of the most significant challenges in modern molecular methods. Data must be examined within the context of complex biological processes, and rapidly increasing throughput makes analyses time and labor intensive. QIAGEN’s portfolio of powerful tools addresses this bottleneck with innovative applications based on cutting-edge bioinformatics.

QIAGEN Digital Insights Website   QIAGEN Website